Global biotechnology organizations are looking to digitally evolve their R&D operations but are often hindered by outdated legacy systems that slow their ability to bring new products to market. The most innovative companies are actively modernizing their infrastructure with cutting-edge digital solutions that better connect and manage data across the organization, drive collaboration among teams, and improve the efficiency of their R&D programs. In this webinar, you’ll learn how teams within biotechnology pioneer Genentech's R&D division are leveraging such solutions to continue to set the pace of innovation.
Loren Perelman is Benchling’s Head of Enterprise Professional Services. His career has been focused on helping organizations make better use of their primary asset, data, by improving methods of collection and utilization. Prior to Benchling, Loren was Vice President of Scientific Solutions at Riffyn, working with various customers in the Biotech and Biopharma spaces. Before Riffyn, he spent over a decade leading R&D, Process Development, and Manufacturing teams in those same spaces, with a focus on quality, analytical chemistry, and stats/modeling. His education includes a PhD in Materials Science from UCSD and a B.S. in Chemistry from Harvey Mudd College.
Erik Bierwagen is a Director of Discovery Platforms and Model Systems Informatics, and Principal Research Software Engineer in the Research Informatics & Software Engineering (RI&SE) department. He has been active in scientific data management for his entire professional career. He has been at Genentech since 2003, and during that time he has collaborated with many groups in Research to develop informatics solutions that simultaneously capture data properly and efficiently at the point of origin and allow for reuse in many other contexts. His group is currently responsible for many systems and services, from infrastructure and services such as Benchling and application support, to more user-facing systems such as Cell Engineering and Animal Management systems. He received his PhD from Caltech in computational chemistry, and moved into software and scientific data management upon completion of his doctorate.
Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News.